Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies-Reference-Cited by-同舟云学术

Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies

Published:2009-01 Issue:7 Volume:44 Page:774-781
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Bendtzen Klaus,Ainsworth Mark,Steenholdt Casper,Thomsen Ole Østergaard,Brynskov Jørn

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

http://www.tandfonline.com/doi/pdf/10.1080/00365520802699278

Reference42 articles.

1. Tumour necrosis factor and Crohn's disease.

2. Anti-tnfα therapy is useful in rheumatoid arthritis and crohn’s disease: analysis of the mechanism of action predicts utility in other diseases

3. Inflammatory bowel disease: clinical aspects and established and evolving therapies

4. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

5. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐Term Follow‐Up of Anti‐Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering;Arthritis & Rheumatology;2024-07-14

2. Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development;Antibodies;2024-02-26

3. Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease;Medicina;2024-01-31

4. Effect of NLRP3 inflammasome genes polymorphism on disease susceptibility and response to TNF-α inhibitors in Iraqi patients with rheumatoid arthritis;Heliyon;2023-06

5. Labordiagnostik;Pflege bei chronisch-entzündlichen Darmerkrankungen;2023